From: PELI1: key players in the oncogenic characteristics of pancreatic Cancer
Parameter | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | ||
Age | < 60 | 18.53 | 15.13–21.92 | 0.223 | |||
≥ 60 | 16.88 | 14.60–19.17 | |||||
Gender | Male | 19.93 | 17.15–22.71 | 0.005 | |||
Female | 14.29 | 11.77–16.81 | 1.601 | 0.95–2.69 | 0.007 | ||
Tumor size | < 5 | 20.20 | 17.87–22.51 | 0.001 | |||
≥ 5 | 12.31 | 9.25–15.37 | 0.833 | 0.46–1.52 | 0.55 | ||
pTNM stage | I-II | 23.01 | 20.54–25.48 | < 0.001 | |||
III-IV | 10.27 | 8.62–11.92 | 2.09 | 0.97 ~ 4.49 | 0.06 | ||
T stage | I-II | 22.12 | 19.10–25.13 | <0.001 | |||
III-IV | 13.21 | 11.12–15.30 | 1.52 | 0.78 ~ 2.96 | 0.22 | ||
Lymphatic node metastasis | N0 | 23.56 | 19.56–22.80 | < 0.001 | |||
N1 | 14.53 | 12.62–16.45 | 1.07 | 0.57 ~ 2.00 | 0.841 | ||
Distantly metastasized | M0 | 20.89 | 18.60–23.18 | < 0.001 | |||
M1 | 9.03 | 7.23–10.82 | 3.168 | 1.64 ~ 6.12 | 0.001 | ||
Number of foci | Single | 18.03 | 15.55–20.50 | 0.572 | |||
Multiple | 16.82 | 13.11–20.54 | |||||
Vascular invasion | No | 19.55 | 16.63–22.47 | 0.035 | |||
Yes | 15.13 | 12.60–17.65 | 0.92 | 0.55 ~ 1.56 | 0.761 | ||
Nerve violation | No | 18.44 | 14.60–22.29 | 0.508 | |||
Yes | 17.13 | 14.88–19.39 | |||||
Degree of differentiation | Low | 16.143 | 13.23–19.06 | 0.341 | |||
Middle | 18.944 | 15.60–21.89 | |||||
High | 15.214 | 11.40–19.03 | |||||
PELI1 IHC Score | 1.41 | 1.27–1.56 | < 0.001 | 1.24 | 1.08–1.42 | 0.002 | |
CEA | 1.007 | 0.99–1.01 | 0.08 | ||||
CA19–9 | 1.00 | 1.00–1.001 | 0.497 |